Life Sciences Nova Scotia
  • About
    • COL
      • Who we are
      • What we do
    • COL
      • Why work in Nova Scotia?
    • COL
      • Contact us
  • Members
    • COL
      • Member directory
    • COL
      • Member benefits
    • COL
      • Become a member
  • Resources
    • COL
      • Member Programs
    • COL
      • News & success stories
    • COL
      • Member Job Board
  • Events
  • Podcast
Select Page

Chelation Partners Presents Data on Their Lead Non-Antibiotic Anti-Infective Compound at the 2018 Kansas City Animal Health Investment Forum

by administrator | Sep 13, 2018 | Chelation Partners, News

Halifax company fighting antibiotic-resistant superbugs

by administrator | Aug 30, 2017 | Chelation Partners, News

Link to original story here A Halifax company is testing a new chemical compound that acts like a magnet to break down the defences of antibiotic-resistant superbugs by depriving them of the one thing they all need — iron. Chelation Partners Inc. has been working for...

Recent Posts

  • 3D BioFibR Appoints Dr. Michael Francis as Independent Board Member
  • Life Sciences Nova Scotia Announces the appointment of 5 New Board Members
  • BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing
  • Federal Government Prescribes $2.9M Boost For Life Sciences Sector
  • Entrevestor Live – An Awesome Display of Atlantic Canadian Innovation
No comments to show.

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow